These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27998160)

  • 1. Risk factors of Multiple sclerosis and their Relation with Disease Severity: A Cross-sectional Study from Iran.
    Abbasi M; Nabavi SM; Fereshtehnejad SM; Ansari I; Zerafatjou N; Shayegannejad V; Mohammadianinejad SE; Farhoudi M; Noorian A; Razazian N; Abedini M; Faraji F
    Arch Iran Med; 2016 Dec; 19(12):852-860. PubMed ID: 27998160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; De Keyser J
    Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual dysfunction levels in iranian women suffering from multiple sclerosis.
    Dehghan-Nayeri N; Khakbazan Z; Ghafoori F; Nabavi SM
    Mult Scler Relat Disord; 2017 Feb; 12():49-53. PubMed ID: 28283107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported levels of education and disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Van Remoortel A; De Keyser J; Nagels G
    Acta Neurol Scand; 2016 Dec; 134(6):414-419. PubMed ID: 27761897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control study of risk factors for multiple sclerosis in Iran.
    Alonso A; Cook SD; Maghzi AH; Divani AA
    Mult Scler; 2011 May; 17(5):550-5. PubMed ID: 21325015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking and progression in multiple sclerosis.
    Koch M; van Harten A; Uyttenboogaart M; De Keyser J
    Neurology; 2007 Oct; 69(15):1515-20. PubMed ID: 17923613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
    Roudbari SA; Ansar MM; Yousefzad A
    J Neurol Sci; 2013 Jul; 330(1-2):52-5. PubMed ID: 23628463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 8-year study of people with multiple sclerosis in Isfahan, Iran: Association between environmental air pollutants and severity of disease.
    Ashtari F; Esmaeil N; Mansourian M; Poursafa P; Mirmosayyeb O; Barzegar M; Pourgheisari H
    J Neuroimmunol; 2018 Jun; 319():106-111. PubMed ID: 29526408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking and associated risk of multiple sclerosis in the Iranian population.
    Asadollahi S; Fakhri M; Heidari K; Zandieh A; Vafaee R; Mansouri B
    J Clin Neurosci; 2013 Dec; 20(12):1747-50. PubMed ID: 23972559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for increased multiple sclerosis susceptibility in the Iranian population.
    Mansouri B; Asadollahi S; Heidari K; Fakhri M; Assarzadegan F; Nazari M; Divani A
    J Clin Neurosci; 2014 Dec; 21(12):2207-11. PubMed ID: 25082407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.
    Eskandarieh S; Nedjat S; Abdollahpour I; Moghadasi AN; Azimi AR; Sahraian MA
    Mult Scler Relat Disord; 2017 Feb; 12():39-43. PubMed ID: 28283104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in Iranian patients with multiple sclerosis: a cross-cultural study.
    Pakpour AH; Yekaninejad MS; Mohammadi NK; Molsted S; Zarei F; Patti F; Harrison A
    Neurol Neurochir Pol; 2009; 43(6):517-26. PubMed ID: 20054754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK.
    Orme M; Kerrigan J; Tyas D; Russell N; Nixon R
    Value Health; 2007; 10(1):54-60. PubMed ID: 17261116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context.
    He A; Manouchehrinia A; Glaser A; Ciccarelli O; Butzkueven H; Hillert J; McKay KA
    JAMA Netw Open; 2023 Sep; 6(9):e2334675. PubMed ID: 37751208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
    Kaminska M; Kimoff RJ; Benedetti A; Robinson A; Bar-Or A; Lapierre Y; Schwartzman K; Trojan DA
    Mult Scler; 2012 Aug; 18(8):1159-69. PubMed ID: 22183937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors.
    Guimond C; Lee JD; Ramagopalan SV; Dyment DA; Hanwell H; Giovannoni G; Criscuoli M; Yee IM; Vorobeychik G; Ebers GC; Sadovnick AD
    Mult Scler; 2014 Aug; 20(9):1182-8. PubMed ID: 24414537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
    Roxburgh RH; Seaman SR; Masterman T; Hensiek AE; Sawcer SJ; Vukusic S; Achiti I; Confavreux C; Coustans M; le Page E; Edan G; McDonnell GV; Hawkins S; Trojano M; Liguori M; Cocco E; Marrosu MG; Tesser F; Leone MA; Weber A; Zipp F; Miterski B; Epplen JT; Oturai A; Sørensen PS; Celius EG; Lara NT; Montalban X; Villoslada P; Silva AM; Marta M; Leite I; Dubois B; Rubio J; Butzkueven H; Kilpatrick T; Mycko MP; Selmaj KW; Rio ME; Sá M; Salemi G; Savettieri G; Hillert J; Compston DA
    Neurology; 2005 Apr; 64(7):1144-51. PubMed ID: 15824338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China.
    Zhang Y; Liu G; Han X; Dong H; Geng J
    J Neuroimmunol; 2016 Aug; 297():127-31. PubMed ID: 27397085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.